Chlamydia Vaccine Candidate Granted Fast Track Designation by the US FDA
Paris, March 26, 2025. The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of the vaccine candidate to...
